-
EP3094648
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP3094648
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2014006217
[XA] (GENMAB BV et al.) [X] 1-5,7-9,11,12,14,18,19 * page 47, paragraphs 1-2 * * page 40, paragraph 4 - page 43, paragraph 7 * * claims 1-34,43-47 * * tables 13-12 * * page 87, paragraph 3 *[A] 10,17 | Type: | Patent literature | Publication No.: | US2010272720
[XA] (LO KIN-MING et al.) [X] 1-3,5-8,12,14,18,19 * paragraphs [0003] , [0 52] , [0053] , [0055] , [0060] , [0080] * * claims 1-10,33 *[A] 9,10,13,15-17 | Type: | Patent literature | Publication No.: | US2008112961
[XAI] (STAVENHAGEN JEFFREY B et al.) [X] 1-3,5,7,8,11,12,14,18,19 * claims 1-5 * * paragraphs [0042] , [0049] , [0 87] , [0 92] , [0197] , [0208] , [ 227] , [0266] * * tables 1,3-10 *[A] 9 [I] 4,6,10,13,15,17 | Type: | Patent literature | Publication No.: | US6277375
[XI] (WARD ELIZABETH SALLY et al.) [X] 1-3,5,18,19 * example 9 * * column 59, paragraphs 2-3 * * column 60, paragraph 3 * * column 12, paragraphs 4-5 *[I] 4 | Type: | Patent literature | Publication No.: | WO2013004842
[XAI] (GENMAB AS et al.) [X] 1-8,11,12,14,18,19 * claims 1-29,40,42-43,56-57,68-78 * * table 1 * * page 38 - page 40 * * page 59, paragraph 3 - page 76, paragraph 6 *[A] 9,10 [I] 1 | Type: | Patent literature | Publication No.: | AU2012233313
[I] (CHUGAI PHARMACEUTICAL CO LTD et al.) [I] 1-19 * page 88, paragraph 3 - page 89, paragraph 1 * * claims 1-5 * * page 98, paragraph last - page 99 * * example 12 * | Type: | Non-patent literature | Publication information: | [XA] T. YING ET AL: "Soluble Monomeric IgG1 Fc", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 287, no. 23, 1 June 2012 (2012-06-01), pages 19399 - 19408, XP055063702, ISSN: 0021-9258, DOI: 10.1074/jbc.M112.368647 [X] 1-3,5,8,11,12,18,19 * the whole document * * figure 6 * * page 19401, column 1, paragraph 4 * * page 19403, column 2, paragraph 3 * [A] 7,9,10 | DOI: | http://dx.doi.org/10.1074/jbc.M112.368647 | Type: | Non-patent literature | Publication information: | [X] MARTIN W L ET AL: "Crystal Structure at 2.8A of an FcRn/Heterodimeric Fc Complex: Mechanism of pH-Dependent Binding", MOLECULAR CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 7, 1 April 2001 (2001-04-01), pages 867 - 877, XP003027710, ISSN: 1097-2765, DOI: 10.1016/S1097-2765(01)00230-1 [X] 1-3,5,12,18,19 * the whole document * * tables 3,4 * | DOI: | http://dx.doi.org/10.1016/S1097-2765(01)00230-1 | Type: | Non-patent literature | Publication information: | [XAI] SHIELDS R L ET AL: "High resolution mapping of the binding site on human IgG1 for FcgammaRI, FcgammaRII, FcgammaRIII, and FcRn and design of IgG1 variants with improved binding to the FcgammaR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 276, no. 9, 2 March 2001 (2001-03-02), pages 6591 - 6604, XP002271092, ISSN: 0021-9258, DOI: 10.1074/JBC.M009483200 [X] 1-3,5,7,12,18,19 * the whole document * * tables I,III * * page 6603, column 1, paragraph 2 *[A] 9,10,13-15 [I] 4 | DOI: | http://dx.doi.org/10.1074/jbc.M009483200 | Type: | Non-patent literature | Publication information: | [A] KIM H ET AL: "FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye", vol. 15, 16 December 2009 (2009-12-16), pages 2803 - 2812, XP002688851, ISSN: 1090-0535, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | [A] TIMOTHY T KUO ET AL: "Neonatal Fc Receptor: From Immunity to Therapeutics", JOURNAL OF CLINICAL IMMUNOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 30, no. 6, 1 October 2010 (2010-10-01), pages 777 - 789, XP019858481, ISSN: 1573-2592, DOI: 10.1007/S10875-010-9468-4 [A] 1-19 * the whole document * | DOI: | http://dx.doi.org/10.1007/s10875-010-9468-4 | Type: | Non-patent literature | Publication information: | [A] KIM J-K ET AL: "Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 29, no. 9, 1 September 1999 (1999-09-01), pages 2819 - 2825, XP002300286, ISSN: 0014-2980, DOI: 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6 [A] 1-19 * the whole document * | DOI: | http://dx.doi.org/10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6 | Cited in | Examination | Type: | Patent literature | Publication No.: | WO2014177461
| Type: | Patent literature | Publication No.: | WO2014177460
|